Effect of DASH vs. mediterranean diet accompanied by a salt restriction on metabolic syndrome and cardiometabolic risk factors in adults with high normal blood pressure or grade 1 hypertension: secondary analyses of a randomized controlled trial.
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension.
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, Zhu L, Hu F, Li X, Meng S, Yan R, Zhao S, Onwuka JU, Yang B, Sun D, Zhao Y.
J Am Heart Assoc. 2020 Oct 20;9(19):e016804. doi: 10.1161/JAHA.120.016804. Epub 2020 Sep 25.
National and Provincial-Level Prevalence and Risk Factors of Carotid Atherosclerosis in Chinese Adults.
Fu J, Deng Y, Ma Y, Man S, Yang X, Yu C, Lv J, Wang B, Li L.
JAMA Netw Open. 2024 Jan 2;7(1):e2351225. doi: 10.1001/jamanetworkopen.2023.51225.
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.
Hofmeyr GJ, Lawrie TA, Atallah ÁN, Torloni MR.
Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD001059. doi: 10.1002/14651858.CD001059.pub5.
Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis.
Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, Chen K, Sha W, Zhang C, Chen H.
BMJ. 2020 Sep 9;370:m3222. doi: 10.1136/bmj.m3222.
Effect of DASH vs. mediterranean diet accompanied by a salt restriction on metabolic syndrome and cardiometabolic risk factors in adults with high normal blood pressure or grade 1 hypertension: secondary analyses of a randomized controlled trial.
Filippou CD, Thomopoulos CG, Konstantinidis DG, Dimitriadis KS, Chrysochoou CA, Tatakis FA, Siafi EP, Tousoulis DM, Nihoyannopoulos PI, Panagiotakos DB, Tsioufis KP.
Hellenic J Cardiol. 2025 Sep-Oct;85:24-37. doi: 10.1016/j.hjc.2024.05.006. Epub 2024 May 21.
Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis.
Ranpura V, Pulipati B, Chu D, Zhu X, Wu S.
Am J Hypertens. 2010 May;23(5):460-8. doi: 10.1038/ajh.2010.25. Epub 2010 Feb 25.
Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension.
Huang Y, Wan T, Hong Y, Wang X, Jiang X, Yang 杨洋 Y, Gao H, Ji J, Wang L, Yang 杨阳 Y, Li X, Wang H.
Hypertension. 2025 Jun;82(6):1012-1023. doi: 10.1161/HYPERTENSIONAHA.124.24252. Epub 2025 Apr 23.
COVID-19-Associated Glomerular Disease.
Shetty AA, Tawhari I, Safar-Boueri L, Seif N, Alahmadi A, Gargiulo R, Aggarwal V, Usman I, Kisselev S, Gharavi AG, Kanwar Y, Quaggin SE.
J Am Soc Nephrol. 2021 Jan;32(1):33-40. doi: 10.1681/ASN.2020060804. Epub 2020 Nov 19.
Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice.
Daskalopoulou SS, Papacostas-Quintanilla H, Brzozowska-Villatte R; the Study Investigators.
Adv Ther. 2025 Feb;42(2):1108-1130. doi: 10.1007/s12325-024-03091-6. Epub 2024 Dec 28.
Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.
Lee CJ, Hwang J, Kang CY, Kim HC, Ryu DR, Ihm SH, Kim YJ, Shin JH, Pyun WB, Kim C, Park S.
J Hypertens. 2021 Aug 1;39(8):1662-1669. doi: 10.1097/HJH.0000000000002820.
